Thank you for inviting Senator Tillis’ office to participate in this listening session. Panelists were asked to address an issue impacting drug affordability and accessibility. I appreciate the ...

Patent searches are often insufficient to invalidate SEPs. It’s an art, and one must develop a unique strategy for each case.

In the latest development on USPTO Director Coke Morgan Stewart’s “settled expectations” doctrine, Stewart today denied ...

The term “AI agent” is everywhere, but what does it actually mean for your patent practice? This webinar cuts through the ...

The Council for Innovation Promotion (C4IP) today issued a statement taking Congress to task for supporting a bill introduced ...

Late last week, President Donald Trump sent letters to 17 pharmaceutical companies pressing them to deliver on his May ...

Our conversation this week is about PTAB practice and how it has evolved over the last several months; we specifically ...

On Friday, August 1, the U.S. Court of Appeals for the Federal Circuit (CAFC) issued a precedential ruling in FMC Corp. v.

Last week, reports surfaced that spokespeople from the European Commission had confirmed the official withdrawal of ...

Patent Bots, creator of AI-enabled software for patent attorneys, is well known for its annual Patent Quality Rankings. The ...

In the latest slew of Director Discretionary Denial decisions issued last week by the U.S. Patent and Trademark Office (USPTO), Acting USPTO Director Coke Morgan Stewart largely delivered wins for ...

In a recent letter sent to U.S. Trade Representative Jamieson Greer and Secretary of Commerce Howard Lutnick,18 Republican ...